Effects of Aramchol in patients with nonalcoholic fatty liver disease (NAFLD). A systematic review and meta-analysis

INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) comprises a wide range of related liver disorders affecting mainly people who drink no or very little alcohol. Aramchol is a new synthetic molecule that has been shown to reduce liver fat content. There is little evidence supporting its efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Adnan, Nadeem, Mahum, Amjad, Waseem, Malik, Muhammad Imran, Javaid, Sadia, Farooq, Umer, Naseem, Khadija, Khan, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050975/
https://www.ncbi.nlm.nih.gov/pubmed/37007760
http://dx.doi.org/10.5114/pg.2022.113573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050975/
https://www.ncbi.nlm.nih.gov/pubmed/37007760
http://dx.doi.org/10.5114/pg.2022.113573

Ejemplares similares